Back to Search
Start Over
Linked-Color Imaging Detects More Colorectal Adenoma and Serrated Lesions: An International Randomized Controlled Trial.
- Source :
- Clinical Gastroenterology & Hepatology; Jun2023, Vol. 21 Issue 6, p1493-1493, 1p
- Publication Year :
- 2023
-
Abstract
- Effects of linked-color imaging (LCI) on colorectal lesion detection and colonoscopy quality remain controversial. This study compared the detection rates of adenoma and other precursor lesions using LCI vs white-light imaging (WLI) during screening, diagnostic, and surveillance colonoscopies. This randomized controlled trial was performed at 11 institutions in 4 Asian countries/regions. Patients with abdominal symptoms, a primary screening colonoscopy, positive fecal immunochemical test results, or undergoing postpolypectomy surveillance were recruited and randomly assigned in a 1:1 ratio to either the LCI or high-definition WLI group. The primary outcome was adenoma detection rate (ADR). Secondary outcomes were polyp detection rate, advanced ADR, sessile serrated lesion (SSL) detection rate, and the mean number of adenomas per colonoscopy. The recommended surveillance schedule distribution after trial colonoscopy was analyzed. Between November 2020 and January 2022, there were 3050 participants (LCI, n = 1527; WLI, n = 1523) recruited. The LCI group ADR was significantly higher than the WLI group ADR using intention-to-treat (58.7% vs 46.7%; P <.01) and per-protocol analyses (59.6% vs 46.4%; P <.01). The LCI group polyp detection rates (68.6% vs 59.5%; P <.01), SSL detection rates (4.8% vs 2.8%; P <.01), and adenomas per colonoscopy (1.48 vs 1.02; P <.01) also were significantly higher. However, the advanced ADR was not significantly different (13.2% vs 11.0%; P =.06). Significantly more patients in the LCI group had shorter recommended surveillance schedules than the WLI group (P <.01). Compared with WLI, LCI improved adenoma and other polyp detection rates, including SSLs, resulting in alteration of the recommended surveillance schedule after screening, diagnostic, and postpolypectomy surveillance colonoscopies. Trial registration number: UMIN000042432 (https://www.umin.ac.jp/ctr/index.htm). [Display omitted] [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 15423565
- Volume :
- 21
- Issue :
- 6
- Database :
- Supplemental Index
- Journal :
- Clinical Gastroenterology & Hepatology
- Publication Type :
- Academic Journal
- Accession number :
- 163715044
- Full Text :
- https://doi.org/10.1016/j.cgh.2022.10.021